An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
CTS Corporation Announces Appointment of Amy M. Dodrill to its Board of Directors
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Positive)
Tags
management
Rhea-AI Summary
CTS Corporation appoints Amy M. Dodrill to its board of directors, effective February 8, 2024. Ms. Dodrill brings over 25 years of experience in medical and technology companies, with a proven track record of leading and growing global businesses. She most recently served as President of Baxter’s Global Surgical Solutions and Patient Support Systems segment. CTS looks forward to leveraging her expertise to drive growth, end-market diversification, and innovative product development.
Positive
None.
Negative
None.
LISLE, Ill., Feb. 08, 2024 (GLOBE NEWSWIRE) -- CTS Corporation (NYSE: CTS), a leading global designer and manufacturer of custom engineered solutions that “Sense, Connect and Move,” today announced that Amy M. Dodrill has been appointed to its board of directors, effective February 8, 2024, and will serve as a member of the nominating, governance and sustainability and technology and transactions committees.
Ms. Dodrill comes to CTS with over 25 years of experience in medical and technology companies and a proven track record of successfully leading and profitably growing global businesses serving key end markets. Ms. Dodrill most recently served as President of Baxter’s Global Surgical Solutions and Patient Support Systems segment, a $2 billion business with innovative products focused on advancing connected care and patient outcomes. In that role, Ms. Dodrill successfully integrated two former Hillrom business units into Baxter. Ms. Dodrill is a member of the board of directors of Procept BioRobotics (NASDAQ: PRCT), a commercial stage surgical robotics company, serving on the audit and compensation committees.
"CTS is pleased to welcome Amy Dodrill to the CTS board. Her extensive experience in the medical end market and background leading global businesses make her a valuable addition to our already highly experienced and diverse group of directors as CTS continues to focus on growth, end-market diversification, and products that sense, connect and move," said Kieran O’Sullivan, Chairman, President and CEO of CTS.
About CTS CTS (NYSE: CTS) is a leading designer and manufacturer of products that Sense, Connect, and Move. The company manufactures sensors, actuators, and electronic components in North America, Europe, and Asia, and provides engineered products to customers in the aerospace/defense, industrial, medical, and transportation markets. For more information, visit www.ctscorp.com.
Contact Ashish Agrawal Vice President and Chief Financial Officer
CTS Corporation 4925 Indiana Avenue Lisle, IL 60532 USA
Amy M. Dodrill has been appointed to CTS Corporation's board of directors, effective February 8, 2024.
Amy M. Dodrill has over 25 years of experience in medical and technology companies, with a proven track record of leading and growing global businesses. She most recently served as President of Baxter’s Global Surgical Solutions and Patient Support Systems segment.
The ticker symbol for CTS Corporation is CTS.
Kieran O’Sullivan is the Chairman, President, and CEO of CTS Corporation.
Procept BioRobotics' ticker symbol is PRCT.
CTS Corporation is a leading global designer and manufacturer of custom engineered solutions that 'Sense, Connect and Move.'
cts (nyse: cts) is a designer and manufacturer of sensors, actuators and electronic components for original equipment manufacturers (oems) in the aerospace, communications, defense, industrial, information technology, medical and transportation markets. cts aims to be a leading provider of sensing and motion devices as well as connectivity components, enabling an intelligent and seamless world. this is accomplished by maintaining a strategy of investing in innovative products that fulfil the cts value proposition - sense, connect and move. cts manufactures products in north america, europe and asia.
